Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WellPoint Seeks More Quality Of Life, Cost Data In Formulary Submissions

Executive Summary

WellPoint's updated formulary submission guidelines aim to give drug companies more detailed advice on submitting information on a drug's cost-effectiveness and its impact on pharmacy and medical budgets, as well as its effectiveness in improving patients' quality of life
Advertisement

Related Content

WellPoint Plans CER Guidance, Building On Progress With Outcomes Data
Building A Biopharma Product's Reimbursement Into Deals
One Payer's Perspective On CER: WellPoint Wants Real-World Applicability
Quality of Life Claims In Sanctura Journal Advertisement Cited By FDA
Comparative Effectiveness Needs Holistic Value Measures – Amgen Exec
New Drugs For Rare Diseases Facing Higher Reimbursement Hurdles
Insurers View JUPITER With Caution; Can Benefit Be Achieved With Generics?
With A New Administration, The Same FDA? Policy Trends Seem Unlikely To Shift
WellPoint Aiming For Mandatory Formulary Submission Standards In 2009
WellPoint Aiming For Mandatory Formulary Submission Standards In 2009
Advertisement
UsernamePublicRestriction

Register

PS050277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel